Endothelial dysfunction in diabetes
Open accessThe DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Endothelial dysfunction plays a key role in the pathogenesis of diabetic vascular disease. The endothelium controls the tone of the underlying vascular smooth muscle through the production of vasodilator mediators. The endothelium‐derived relaxing factors (EDRF) comprise nitric oxide (NO), prostacyclin, and a still elusive endothelium‐derived hyperpolarizing factor (EDHF). Impaired endothelium‐dependent vasodilation has been demonstrated in various vascular beds of different animal models of diabetes and in humans with type 1 and 2 diabetes. Several mechanisms of endothelial dysfunction have been reported, including impaired signal transduction or substrate availibility, impaired release of EDRF, increased destruction of EDRF, enhanced release of endothelium‐derived constricting factors and decreased sensitivity of the vascular smooth muscle to EDRF. The principal mediators of hyperglycaemia‐induced endothelial dysfunction may be activation of protein kinase C, increased activity of the polyol pathway, non‐enzymatic glycation and oxidative stress. Correction of these pathways, as well as administration of ACE inhibitors and folate, has been shown to improve endothelium‐dependent vasodilation in diabetes. Since the mechanisms of endothelial dysfunction appear to differ according to the diabetic model and the vascular bed under study, it is important to select clinically relevant models for future research of endothelial dysfunction. British Journal of Pharmacology (2000) 130 , 963–974; doi: 10.1038/sj.bjp.0703393
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both hyperglycemia and hyperinsulinemia alter the endothelium,27 disrupting the normal atheroprotective nitric oxide regulatory environment and encouraging a generalized proinflammatory, vasoconstrictive state predisposing to atherothrombosis.27–29”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“Impaired endothelium-dependent vasodilation has been demonstrated in various vascular beds of animal models of diabetes and humans with type 1 and type 2 diabetes (80).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441 · cited 1×
“Although AGE formation occurs during the normal ageing process, it is markedly accelerated during diabetes, as a consequence of an increase in substrate, e.g. glucose, and in the prevailing oxidant stress in this disease (Baynes & Thorpe, 1999).”
BackgroundEndothelium‐derived relaxing and contracting factors
Furchgott, R. F., & Vanhoutte, P. M. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.9.2545495 · Cited by 1,993
Self-citationOxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,930
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Wolff, S. P., & Dean, R. T. (1987) · Biochemical Journal · doi:10.1042/bj2450243 · Cited by 1,271
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
Rubanyi, G. M., & Vanhoutte, P. M. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.5.h822 · Cited by 1,188
Self-citationBucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,124
Research works printed but not linked: 6
- DE VRIESE A., 1999, Impaired endothelium‐derived hyperpolarizing factormediated renal vasodilatory response in diabetes: restoration with folate, J. Am. Soc. Nephrol., 10, 394A
- FRIEDMAN E.A., 1999, Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications, Diabetes Care, 22, B65
- FULTON D., 1996, Cytochrome P450 arachidonate metabolites: deficit in diabetes mellitus, FASEB J., 9, A113
- QUILLEY J., 1996, NO‐independent coronary vasodilation to bradykinin in diabetes, Hypertension, 28, P178
- 10.2337/diabetes.42.9.1246 · doi:10.2337/diabetes.42.9.1246
- 10.1042/cs19980382 · doi:10.1042/cs19980382
Cited by
Items 701–800 of 1,000
Redox Signaling and Regional Heterogeneity of Endothelial Dysfunction in db/db Mice
Sallam, N. A., & Laher, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176147 · Cited by 17
Hein, M., Qambari, H., An, D., & Balaratnasingam, C. (2024) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.14363 · Cited by 17
“5,53 Dysfunction of endothelial cells is one of the earliest changes in clinical DR and is thought to contribute to many pathologic features such as leakage, vessel occlusion, leukos-tasis, thrombosis and microaneurysms.”
BackgroundHuman vitreal prostaglandin levels and proliferative diabetic retinopathy
Douros, S., Phillips, B. A., Nadel, A. J., & Obstbaum, S. A. (2001) · Documenta Ophthalmologica · doi:10.1023/a:1017557600233 · Cited by 17
“In addition, it is not presently clear how prostaglandins might interact to modulate endothelium-dependent relaxations in diabetic vasculature, but the impaired responses in diabetic vessels may be related to a decreased release of vasodilatory prostanoids [2].”
BackgroundInfluentialNade, V. S., Kawale, L., & Patel, K. (2015) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.151604 · Cited by 17
“Endothelial dysfunction is a clinical feature of metabolic syndrome; there is decreased availability of endothelium derived NO for proper vasodilatation to occur[27,28].”
BackgroundGokina, N. I., Bonev, A. D., Gokin, A. P., & Goloman, G. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00513.2012 · Cited by 17
Vasoactive actions of nitroxyl (HNO) are preserved in resistance arteries in diabetes
Tare, M., Kalidindi, R. S. R., Bubb, K. J., Parkington, H. C., Boon, W., Li, X., Sobey, C. G., Drummond, G. R., Ritchie, R. H., & Kemp‐Harper, B. K. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1336-1 · Cited by 17
Sexual Dysfunction in Men and Women
Bhasin, S., & Basson, R. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00020-4 · Cited by 17
The Role of Platelets in Diabetes Mellitus
Santilli, F., Simeone, P., & Liani, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00027-8 · Cited by 17
Morphological and Functional Characteristics of Blood and Lymphatic Vessels
Hantusch, B. (2019) · Learning materials in biosciences · doi:10.1007/978-3-030-12270-6_1 · Cited by 17
Guzmán‐Gutiérrez, E., Veas, C., Leiva, A., Escudero, C., & Sobrevía, L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00136 · Cited by 17
“…diabetes (GD) is associated with higher synthesis and release of vasodilators such as nitric oxide (NO) in the human fetal endothelium from GD (described as altered endothelial function) (De Vriese et al., 2000; Guzmán-Gutiérrez et al., 2011; Westermeier et al., 2011; Salomón et al., 2012).”
BackgroundInfluentialInhibitory effect of atorvastatin on AGE-induced HCAEC apoptosis by upregulating HSF-1 protein
Li, Y., Li, J., Cui, L., Lai, Y., Yao, Y., Zhang, Y., Pang, X., Wang, J., & Liu, X. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.03.035 · Cited by 17
Sercombe, R., Vicaut, É., Oudart, N., Sercombe, C., & Girard, P. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000141477.59748.84 · Cited by 17
“Recent reviews on the mechanisms of vascular lesion in diabetes and HG emphasize the complex time- and localization-dependent nature of alterations of vascular function, but all concur on the necessity of ROS scavenging to prevent dysfunction.(58,59,60) The present experiments demonstrate for the”
BackgroundPublisher, B. S. (2006) · Current Vascular Pharmacology · doi:10.2174/157016106778521643 · Cited by 17
“The effects of NO on renal hemodynamics are also conflicting: some studies report blunting of NO-mediated vasorelaxation [133-135], whereas others report enhanced NO-mediated vasorelaxation with markedly impaired endothelial derived hyperpolarizing factor (EDHF) mediated vasorelaxation [136].”
BackgroundShinbori, C., Saito, M., Kinoshita, Y., Satoh, I., Kono, T., Hanada, T., Nanba, E., Adachi, K., Suzuki, H., Yamada, M., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.009 · Cited by 17
“…the endothelium-derived relaxing factors (EDRFs), including nitric 5 oxide (NO ) and prostacyclin (PGI2), enhanced inactivation of EDRF, impaired diffusion of EDRF to the underlying smooth muscle, and enhanced generation of endothelium-derived constricting factors (EDCF) (De Vriese et al., 2000).”
BackgroundMatsumoto, T., Yoshiyama, S., Wakabayashi, K., Kobayashi, T., & Kamata, K. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.09.031 · Cited by 17
Possible role of exogenous cAMP to improve vascular endothelial dysfunction in hypertensive rats
Shah, D. I., & Singh, M. (2006) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2006.00449.x · Cited by 17
Hosoya, M., Ohashi, J., Sawada, A., Takaki, A., & Shimokawa, H. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0862 · Cited by 16
P2X7 receptor and klotho expressions in diabetic nephropathy progression
Rodrigues, A. M., Serralha, R. S., Farias, C., Punaro, G., Fernandes, M. J. D. S., & Higa, E. M. S. (2018) · Purinergic Signalling · doi:10.1007/s11302-018-9602-y · Cited by 16
Haesen, S., Cöl, Ü., Schurgers, W., Evens, L., Verboven, M., Driesen, R. B., Bronckaers, A., Lambrichts, I., Deluyker, D., & Bito, V. (2020) · Scientific Reports · doi:10.1038/s41598-020-68974-4 · Cited by 16
Afzal, S., Sattar, M. Z. A., Johns, E. J., Eseyin, O. A., & Attiq, A. (2021) · PPAR Research · doi:10.1155/2021/6661181 · Cited by 16
“The stiffer artery would lead to an increase in the PWV due to the persistent hyperglycemia leading to depletion of the antioxidant defence mechanism, generating free radicals [81] resulting in endothelial dysfunction and reduced vascular elasticity.”
BackgroundNeuraminidase inhibition improves endothelial function in diabetic mice
Foote, C. A., Ramirez‐Perez, F. I., Smith, J. A. H., Ghiarone, T., Morales‐Quinones, M., McMillan, N. J., Augenreich, M. A., Power, G. J., Burr, K., Aroor, A. R., et al. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00337.2023 · Cited by 16
Effect of demethylasterriquinone b1 in hypertension associated vascular endothelial dysfunction
Shah, D. I., & Singh, M. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.10.006 · Cited by 16
Streeter, E. Y., Badoer, E., Woodman, O. L., & Hart, J. L. (2013) · Physiological Reports · doi:10.1002/phy2.111 · Cited by 16
“Endothelial dysfunction, in both conductance and resistance arteries, is a primary factor in the pathogenesis of vascular disease in both type 1 and type 2 diabetes (de Vriese et al. 2000; Rask-Madsen and King 2007).”
de Godoy, M. A. F., Pernomian, L., de Oliveira, A. M., & Rattan, S. C. (2011) · International Journal of Hypertension · doi:10.1155/2012/121740 · Cited by 16
“consequent endothelial dysfunction [47, 48].”
Bakuy, V., Ünal, O., Gürsoy, M., Kunt, A., Özışık, K., Sargon, M. F., Emir, M., & Şener, E. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2013.09.102 · Cited by 16
“We believe that these changes may lead to disturbance of endothelial dependent vasorelaxation by means of attenuated NO synthesis and increased endothelin-1 as reported by De Vriese and colleagues [24].”
BackgroundChen, Y., Chen, J., Zhou, X., Meng, X., Jiang, J., & Shen, Y. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.00926.x · Cited by 16
Saba, E., Kim, S., Kim, S., Park, S. J., Kwak, D., Oh, J.-H., Park, C.-K., & Rhee, M. H. (2017) · Journal of Ginseng Research · doi:10.1016/j.jgr.2017.04.004 · Cited by 16
“examination of the aortas also showed that endothelial thickening (as indicated by black arrows), associated with a high-fat diet and leading to atheromatic plague formation [20], potentially decreased by Rg3-RGE treatment [Fig.”
BackgroundGenelhu, V. A., Celoria, B. M. J., Pimentel, M. M. G., Duarte, S. F. P., Cabello, P. H., & Francischetti, E. A. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.7 · Cited by 16
Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction
Woodman, O. L., Malakul, W., Cao, A. H., Xu, Q., & Ritchie, R. H. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.01.016 · Cited by 16
Cruz, J. P. D. L., Río, S. D., López-Villodres, J. A., Villalobos, M. A., Jebrouni, N., & Correa, J. A. G. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510000929 · Cited by 16
Effects of hypoxia reoxygenation in brain slices from rats with type 1‐like diabetes mellitus
Correa, J. A. G., Arrebola, M. M., Cansino, A., Muñoz-Marín, J., Ruiz‐Villafranca, D., Guerrero, A., de la Cuesta, F. S., & Cruz, J. P. D. L. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.650 · Cited by 16
“In addition, free radical production and platelet aggregation are increased, giving rise to a vascular state that favors reduced blood flow to tissues and a tendency toward the formation of intravascular thromboses [10–13].”
BackgroundTran, D., Lowy, A. J., Howes, J. B., & Howes, L. G. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00388.x · Cited by 16
Wu, Z., Zheng, X., Meng, L., Fang, X., He, Y., Li, D., Zheng, C., & Zhang, H. (2017) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.02.051 · Cited by 16
Alnaeb, M. E., Thompson, C. S., Seifalian, A. M., Hamilton, G., & Mikhailidis, D. P. (2007) · PubMed · Cited by 16
Oliveira, P. J., Seiça, R. M. F., Santos, D. L., Rolo, A. P., Sardão, V. A., Ferreira, F. M. L., Palmeira, C. M., Santos, M. S., & Moreno, A. J. (2004) · Mitochondrion · doi:10.1016/j.mito.2004.02.005 · Cited by 16
“Endothelial dysfunction associated with diabetes may lead to impaired vasodilatation, causing vascular and cardiac dysfunction (De Vriese, 2000).”
BackgroundHyperglycemia and Diabetes — Induced Vascular Dysfunction: Role of Oxidative Stress
Pieper, G. M. (2000) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-4649-8_16 · Cited by 16
Wajcberg, E., Thoppil, N., Patel, S. S., Fernandez, M., Hale, D. E., DeFronzo, R. A., & Cersósimo, E. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2006.00209.x · Cited by 16
Arginase type I as a marker of coronary heart disease in hemodialysis patients
Eleftheriadis, T., Liakopoulos, V., Antoniadi, G., Stefanidis, I., & Galaktidou, G. (2010) · International Urology and Nephrology · doi:10.1007/s11255-010-9842-4 · Cited by 15
“Because a certain number of HD patients enrolled into the study were diabetics and diabetes mellitus is known to be associated with endothelial dysfunction [ 42 , 43] and to be a strong risk factor for CHD in both general population [44, 45] and HD patients [46], the impact of its presence on the evaluated factors was…”
BackgroundThe Mystery of Exosomes in Gestational Diabetes Mellitus
Chen, T., & Liu, D. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2169259 · Cited by 15
“It is worth noting to mention that clinical trials of common antioxidants in patients with GDM have shown that this method is ine ff ective in reducing oxidative stress [118, 119].”
Sönmez, M. I., Shahzadi, A., KÖSE, Ç., Sönmez, H., Özyazgan, S., & Akkan, A. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.979300 · Cited by 15
Effect of fasudil on macrovascular disorder-induced endothelial dysfunction
Shah, D. I., & Singh, M. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-036 · Cited by 15
Therapeutic strategies for endothelial dysfunction
Deshpande, D., Janero, D. R., & Amiji, M. M. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.625007 · Cited by 15
“Increased glucose flux through the polyol pathway consumes endothelial-cell NADPH [86], and activation of protein kinase C elevates pro-inflammatory arachidonic acid metabolites and inhibits Na--K-ATPase pumps [85].”
BackgroundProtective effect of different flavonoids against endothelial senescence via NLRP3 inflammasome
Sun, C., Wang, X., Zheng, G., Fan, S., Lu, J. L., Zhang, Z., Wu, D., Shan, Q., Hu, B., & Zheng, Y. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.08.031 · Cited by 15
Scordi-Bello, I. A., Kirsch, D. A., & Hammers, J. (2016) · Academic Forensic Pathology · doi:10.23907/2016.022 · Cited by 15
Caspase-14: a novel caspase in the retina with a potential role in diabetic retinopathy.
Al‐Shabrawey, M., Ahmad, S., Megyerdi, S., Othman, A., Baban, B., Palenski, T. L., Shin, E. S., Gürel, Z., Hsu, S., & Sheibani, N. (2012) · PubMed Central · Cited by 15
Activation of Protein Kinase A Improves Vascular Endothelial Dysfunction
Shah, D. I., & Singh, M. (2006) · Endothelium · doi:10.1080/10623320600904047 · Cited by 15
Kamata, K., Hosokawa, M., Matsumoto, T., & Kobayashi, T. (2006) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.42.159 · Cited by 15
Hemodynamics in diabetic human aorta using computational fluid dynamics
Shin, E.-J., Kim, J., Lee, S., Ko, K. S., Rhee, B. D., Han, J., & Kim, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202671 · Cited by 16
Xiao-li, L. I., Li, B., Gao, H., Cheng, M., Ling, X. U., Li, X., & Ma, Y. (2009) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.90008 · Cited by 15
Relaxation by urocortin of rat renal arteries: effects of diabetes in males and females
Sanz, E., Fernández, N., Monge, L., Climent, B., Diéguez, G., & García-Villalón, A. L. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00293-1 · Cited by 15
Effect of bis(maltolato) oxovanadium on experimental vascular endothelial dysfunction
Shah, D. I., & Singh, M. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0066-1 · Cited by 15
Ikumi, Y., Shiroto, T., Godo, S., Saito, H., Tanaka, S., Ito, A., Kajitani, S., Monma, Y., Miyata, S., Tsutsui, M., et al. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000763 · Cited by 14
Stanhewicz, A. E., Schlarmann, R. L., Brustkern, K. M., & Jalal, D. I. (2022) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00189.2022 · Cited by 14
Han, X., Shaligram, S. S., Zhang, R., Anderson, L. C., & Rahimian, R. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0272 · Cited by 14
Prévost, G., Bulckaen, H., Gaxatte, C., Boulanger, É., Béraud, G., Creusy, C., Puisieux, F. L., & Fontaine, P. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.08.005 · Cited by 14
Lian, D., Liu, J., Han, R., Jin, J., Zhu, L., Zhang, Y., Huang, Y., Wang, X., Xian, S., & Chen, Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16747 · Cited by 14
Huang, R., Abdelmoneim, S. S., Nhola, L. F., Basu, R., Basu, A., & Mulvagh, S. L. (2015) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.1015992 · Cited by 14
“However, previous studies [26,27] evaluating the small arteries and arterioles of diabetic subjects have demonstrated that even before the appearance of morphological changes, vasomotor dysfunction develops in these microvessels, affecting both smooth muscle- and endothelium-mediated regulatory mechanisms.”
BackgroundFrame, M. D. S., Dewar, A. M., Chowdhury, S. M., & Sitharaman, B. (2013) · Nanotoxicology · doi:10.3109/17435390.2013.837209 · Cited by 14
“…compromise their ability to regulate flow, in otherwise compromised individuals, including those with metabolic syndrome or other clinically recognized proinflammatory states, the high dosage bolus exposure may compromise their ability to regulate flow (Mustafa et al. 1999; De Vriese et al. 2000).”
BackgroundCunha, A. R., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2008) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2008.00593.x · Cited by 14
“In endothelial cells, hyperglycaemia inhibits eNOS leading to diminished NO production and also increased production of ROS (De Vriese et al. 2000).”
BackgroundPiatti, P. M., Marone, E. M., Mantero, M., Setola, E., Galluccio, E., Lucotti, P., Shehaj, E., Villa, V., Perticone, F., Venturini, M., et al. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0426-x · Cited by 14
Kamata, K., Hosokawa, M., Matsumoto, T., & Kobayashi, T. (2006) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.42.171 · Cited by 14
“…suggests that the relaxation responses induced in aortic strips by endothelium-dependent agents are weaker in streptozotocin (STZ)-induced diabetic rats than in non-diabetic control rats (Kamata et al., 1989, 1999, 2005; Kamata and Kobayashi, 1996; De Vriese et al., 2000; Kobayashi et al., 2000).”
BackgroundSidhu, J. S., & Kaski, J. C. (2001) · Heart · doi:10.1136/heart.86.3.255 · Cited by 14
Update on diabetic retinopathy during pregnancy
Huang, J., Liang, C., Huang, J., & Liu, L. (2024) · European Journal of Ophthalmology · doi:10.1177/11206721241248868 · Cited by 13
“73 Additionally, vessel sizes are sensitive to glucose variations, further complicating data interpretation.”
Mulligan, A. A., Lentjes, M. A. H., Skinner, J. S., & Welch, A. A. (2024) · Antioxidants · doi:10.3390/antiox13080962 · Cited by 14
“Dysfunction of the endothelium, induced by inflammation, has been associated with CVD and hypertension [81] and has also been linked to the development of insulin resistance and type 2 diabetes [82,83].”
BackgroundChen, Q., Gao, X., Wang, C., & Zhang, P. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105624 · Cited by 14
Жарких, Е. В., Loktionova, Y. I., & Dunaev, A. (2024) · Journal of Biophotonics · doi:10.1002/jbio.202400297 · Cited by 13
Güllü, D., Yigci, D., Baykam, N. N., Çelikbaş, A. K., Yapar, D., Akdoğan, Ö., Özden, K., Sarıkaya, R. İ., Hasanoğlu, İ., Güner, R., et al. (2025) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2025.08.009 · Cited by 13
Familial hypercholesterolemia and COVID-19: A menacing but treatable vasculopathic condition
Vuorio, A. F., Strandberg, T. E., Raal, F. J., Santos, R. D., & Kovanen, P. T. (2021) · Atherosclerosis Plus · doi:10.1016/j.athplu.2021.08.001 · Cited by 13
“Endothelial function is also compromised in patients with type 1 or type 2 diabetes [31].”
Kuo, Y., Chien, C., Kuo, M.-J., Wang, F., Huang, E., & Wang, C. (2015) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000001886 · Cited by 13
Sridulyakul, P., Wongeakin, N., & Patumraj, S. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/709695 · Cited by 13
“Figure 4 showed the changes in the ROS-dependent fluorescence intensities detected from the rat mesenteric arterioles and venules of each group at 0 and 1 minute after DHR-123 superfusion.”
BackgroundMethodInfluentialSgarra, L., Addabbo, F., Potenza, M. A., & Montagnani, M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00038.2012 · Cited by 13
“In T2DM patients, both hyperglycemia and insulin resistance contribute independently to endothelial dysfunction, increased vascular stiffness, and atherosclerotic progression (33, 103, 159).”
BackgroundHeitmar, R., Varma, C., De, P., Lau, Y. C., & Blann, A. D. (2016) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-016-3432-9 · Cited by 13
Howarth, A. G., Wiehler, W. B., Pannirselvam, M., Jiang, Y., Berger, J. P., Severson, D. L., Anderson, T. J., & Triggle, C. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086397 · Cited by 13
“…the endothelium has many additional functions beyond the control of vascular tone, this reduced response to ACh serves as an important indicator of vascular dysfunction and has been closely associated with diabetes in both humans and animals (De Vriese et al., 2000; Pannirselvam et al., 2003).”
BackgroundDiabetes and the maternal resistance vasculature
Ang, C., & Lumsden, M. A. (2001) · Clinical Science · doi:10.1042/cs1010719 · Cited by 13
Dias, M. D. F. M., Duarte, J. V., Carvalho, P., & Castelo-Branco, M. S. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf109 · Cited by 12
“59 Regarding Alzheimer’s disease, the sensitivity results evidence that all regions were considered significant regarding the CSF modality, but no region is considered significant on GM, WM and deformation field modalities.”
Sobolevskaya, E. V., Анатольевич, Ш. О., Александрович, С. М., Гуськов, А. Е., Malysheva, A. V., Atuchin∥⊥, V. V., & Nimaev, V. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109096 · Cited by 12
Oniki, H., Gotō, K., Fujii, K., Kansui, Y., Murakami, N., Ohtsubo, T., Matsumura, K., & Kitazono, T. (2012) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2012.702829 · Cited by 12
“In diabetes, the production of reactive oxygen species has been shown to be increased and is likely to be linked to the development of endothelial dysfunction (2,3).”
BackgroundEndothelin-1 Plasma Levels in Hemodialysis Treatment—The Influence of Type 2 Diabetes
Liakopoulos, V., Wurth, P., Mertens, P. R., Eleftheriadis, T., Kourti, P., Voliotis, G., Heintz, B., KOUKOULIS, G. N., & Stefanidis, I. (2005) · Renal Failure · doi:10.1080/08860220500198250 · Cited by 12
“Abnormal endothelial function and activation are known to occur in patients with type 2 diabetes.([14]) Hyperglycemia and hyperinsulinemia have been shown to be accompanied by increased levels of endothelin-1 in animal – 17] and in vitro studies,([18]) whereas in humans with diabetes results are controversial.”
BackgroundMarrachelli, V. G., Miranda, F. J., Alabadí, J. A., Llorens, S., & Alborch, E. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.01.043 · Cited by 12
“Diabetes alters the responsiveness of different vascular beds to several vasoconstrictors and vasodilators, and it has been hypothesised that endothelial dysfunction could partially explain many of these altered responses (Haller, 1997; De Vriese et al., 2000).”
BackgroundAlatrach, M., Agyin, C., Adams, J. M., CHILTON, R. J., Triplitt, C. L., DeFronzo, R. A., & Cersósimo, E. (2018) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.34 · Cited by 12
Preserved endothelial function in young adults with type 1 diabetes
Heier, M., Nygaard, C. S., Brunborg, C., Seljeflot, I., Margeirsdottir, H. D., Hanssen, K. F., Fugelseth, D., & Dahl‐Jørgensen, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206523 · Cited by 12
Ali, S., & Woodman, O. L. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00186 · Cited by 12
4-Hydroxy-2-nonenal attenuates β2-adrenoceptor-mediated vasodilation of rat retinal arterioles
Mori, A., Takei, T., Sakamoto, K., Nakahara, T., & Ishii, K. (2015) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-015-1099-0 · Cited by 12
Effects of endomorphins on human umbilical vein endothelial cells under high glucose
Liu, J., Wei, S., Tian, L., Yan, L., Guo, Q., & Ma, X. (2010) · Peptides · doi:10.1016/j.peptides.2010.09.020 · Cited by 12
Miyamoto, M., Kotani, K., Okada, K., Ando, A., Hasegawa, H., Kanai, H., Ishibashi, S., Yamada, T., & Taniguchi, N. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.16220 · Cited by 12
Effect of Premeasurement Rest Time on Systolic Ankle Pressure
Chuter, V., & Casey, S. L. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000203 · Cited by 12
“PAD commonly coexists with significant systemic atherosclerosis, increasing the risk of cardiac-related morbidity and mortality in conjunction with lower extremity complications including ulceration and amputation.(4,5)”
BackgroundInaba, Y., Tsutsumi, C., Haseda, F., Fujisawa, R., Mitsui, S., Sano, H., Terasaki, J., Hanafusa, T., & Imagawa, A. (2017) · Diabetology International · doi:10.1007/s13340-017-0335-x · Cited by 12
Jung, Y. J., Park, W. S., Nguyen, T. T., Kang, K. P., Jin, H. Y., Kim, S. H., Suh, W., & Kim, W. B. (2017) · Oncotarget · doi:10.18632/oncotarget.21998 · Cited by 12
“Dysfunction and inflammation of endothelial cells in the kidney are critical factors related to diabetic nephropathy [13].”
BackgroundMilieu of Diabetes in the 2nd Decade of 21st Century
Suneja, S., Christian, Y., & Chandra, N. C. (2018) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000804 · Cited by 12
“Diabetes impairs endothelial functions especially affecting the bioavailability of endothelial derived nitric oxide whose major function is to cause vasodilation (Figure 8) [86-89].”
BackgroundBisseling, T. M., Wouterse, A. C., Steegers, E. A. P., Elving, L. D., Rüssel, F. G. M., & Smits, P. (2003) · Placenta · doi:10.1016/s0143-4004(03)00171-1 · Cited by 12
Regulation of endothelin synthesis by extracellular matrix in human endothelial cells
González-Santiago, L., López‐Ongil, S., Griera, M., Rodríguez-Puyol, M., & Rodríguez-Puyol, D. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00466.x · Cited by 12
Kamata, K., Ozawa, Y., Kobayashi, T., & Matsumoto, T. (2008) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.44.177 · Cited by 12
“…and hormones) is a well-established complication of diabetes mellitus (Oyama et al., 1986; Kamata et al., 1989; Poston and Taylor, 1995; De Vriese et al., 2000; Matsumoto et al., 2003a, b, 2006a, 2008; Kobayashi et al., 2005), and a failure of the adaptive coronary flow response to…”
BackgroundRoganović, J., Radenković, M., Tanić, N., Tanić, N., Petrović, N., & Stojić, D. L. (2011) · European Journal Of Oral Sciences · doi:10.1111/j.1600-0722.2011.00851.x · Cited by 11
Mita, M., Kuramoto, T., Ito, K., Toguchi‐Senrui, N., Hishinuma, S., Walsh, M. P., & Shoji, M. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05308.x · Cited by 11
Chiş, I. C., Micu, C.-M., Toader, A. M., Moldovan, R., Lele, L., Clichici, S. V., & Mitrea, D.-R. (2023) · Metabolites · doi:10.3390/metabo13050586 · Cited by 11
Huang, Z., Chu, W. K., Ng, T. K., Chen, S.-L., Liang, J., Chen, C., Xu, Y., Xie, B., Ke, S., Liu, Q., et al. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13439 · Cited by 11
The Effects of Taurine and Thiotaurine on Oxidative Stress in the Aorta and Heart of Diabetic Rats
Mathew, E., Barletta, M. A., & Lau‐Cam, C. A. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-6130-2_28 · Cited by 11
Cytokines as important playmakers of experimental hepatocarcinogenesis confounded by diabetes
Abdel‐Hamid, N. M., Nazmy, M., Abd‐Elghany, M. I., & Nazmy, W. (2012) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31495-4 · Cited by 11
Shaligram, S. S., Akther, F., Razan, M. R., Graham, J. L., Roglans, N., Alegret, M., Parsa, A. G., Stanhope, K. L., Havel, P. J., & Rahimian, R. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173089 · Cited by 11
“Endothelial dysfunction represents an early step in the development of vascular complications in diabetes (Bakker et al., 2009; De Vriese et al., 2000; Ding et al., 2005; McVeigh et al., 1992; Oltman et al., 2006; Takenouchi et al., 2009).”
Lazarov, O., Minshall, R. D., & Bonini, M. G. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.020 · Cited by 11
Metadata
- Authors
- De Vriese, A. S., Verbeuren, T. J., Van de Voorde, J., Lameire, N. H., & Vanhoutte, P. M.
- Affiliations
- Institut Servier (FR)
- Ghent University (BE)
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-07
- Volume
- 130
- Issue
- 5
- Pages
- 963-974
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1572156
- OpenAlex
- W2007880055
- Cited by
- 1,165
- References
- 114
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 32 · 2023: 15 · 2022: 31 · 2021: 27 · 2020: 44 · 2019: 39 · 2018: 41 · 2017: 31 · 2016: 36 · 2015: 50 · 2014: 56 · 2013: 58 · 2012: 62
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- endothelial dysfunction, diabetes mellitus, diabetic vascular disease, endothelium-derived relaxing factor, nitric oxide, prostacyclin, endothelium-derived hyperpolarizing factor, endothelium-dependent vasodilation, protein kinase C, polyol pathway, glycation, oxidative stress, hyperglycemia, ACE inhibitors, folic acid, vascular smooth muscle
- MeSH terms
- Animals, Biological Factors, Diabetes Mellitus, Endothelium, Vascular, Humans, Nitric Oxide, Protein Kinase C, Vasodilation, Signal Transduction, Endothelins, Glycation End Products, Advanced, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.